During the past decade, Santa Casa de Misericordia de Sao Paulo; Hematologia e Hemoterapia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Santa Casa de Misericordia de Sao Paulo; Hematologia e Hemoterapia" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Santa Casa de Misericordia de Sao Paulo; Hematologia e Hemoterapia" are "B-cell Lymphoma" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Santa Casa de Misericordia de Sao Paulo; Hematologia e Hemoterapia" in a lesser frequency.

Most popular intervention types in "Santa Casa de Misericordia de Sao Paulo; Hematologia e Hemoterapia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "CHOP" (1 trials), "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Santa Casa de Misericordia de Sao Paulo; Hematologia e Hemoterapia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Santa Casa de Misericordia de Sao Paulo; Hematologia e Hemoterapia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Santa Casa de Misericordia de Sao Paulo; Hematologia e Hemoterapia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Santa Casa de Misericordia de Sao Paulo; Hematologia e Hemoterapia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".